Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess Efficacy, Safety and Optimal Dose of XC8 in Patients With Partly Controlled Bronchial Asthma Receiving Stable Treatment With Low Doses of Inhaled Corticosteroids With or Without Long-acting beta2-agonists
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Histamine glutarimide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Pharmenterprises
Most Recent Events
- 09 Mar 2018 New trial record